151 related articles for article (PubMed ID: 38492358)
41. Construction and Bioinformatics Analysis of the miRNA-mRNA Regulatory Network in Diabetic Nephropathy.
Li Y; Xu Y; Hou Y; Li R
J Healthc Eng; 2021; 2021():8161701. PubMed ID: 34840704
[TBL] [Abstract][Full Text] [Related]
42. LncRNA-antisense non-coding RNA in the INK4 locus promotes pyroptosis via miR-497/thioredoxin-interacting protein axis in diabetic nephropathy.
Wang J; Zhao SM
Life Sci; 2021 Jan; 264():118728. PubMed ID: 33160992
[TBL] [Abstract][Full Text] [Related]
43. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
Eissa S; Matboli M; Bekhet MM
Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
[TBL] [Abstract][Full Text] [Related]
44. The Role of MicroRNA in the Pathogenesis of Diabetic Nephropathy.
Szostak J; Gorący A; Durys D; Dec P; Modrzejewski A; Pawlik A
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047185
[TBL] [Abstract][Full Text] [Related]
45. Ski-related novel protein suppresses the development of diabetic nephropathy by modulating transforming growth factor-β signaling and microRNA-21 expression.
Wang Y; Liu L; Peng W; Liu H; Liang L; Zhang X; Mao Y; Zhou X; Shi M; Xiao Y; Zhang F; Zhang Y; Liu L; Yan R; Guo B
J Cell Physiol; 2019 Aug; 234(10):17925-17936. PubMed ID: 30847937
[TBL] [Abstract][Full Text] [Related]
46. RETRACTED: Down-regulation of microRNA-21 reduces inflammation and podocyte apoptosis in diabetic nephropathy by relieving the repression of TIMP3 expression.
Chen X; Zhao L; Xing Y; Lin B
Biomed Pharmacother; 2018 Dec; 108():7-14. PubMed ID: 30212710
[TBL] [Abstract][Full Text] [Related]
47. Identification of biomarkers and prediction of upstream miRNAs in diabetic nephropathy.
Yin D; Guo Z; Zhang X
Front Endocrinol (Lausanne); 2023; 14():1144331. PubMed ID: 36896170
[TBL] [Abstract][Full Text] [Related]
48. Roles of microRNA-192 in diabetic nephropathy: the clinical applications and mechanisms of action.
Wan X; Liao J; Lai H; Zhang S; Cui J; Chen C
Front Endocrinol (Lausanne); 2023; 14():1179161. PubMed ID: 37396169
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA-140-5p ameliorates the high glucose-induced apoptosis and inflammation through suppressing TLR4/NF-κB signaling pathway in human renal tubular epithelial cells.
Su J; Ren J; Chen H; Liu B
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32073611
[TBL] [Abstract][Full Text] [Related]
50. miR-188-3p abolishes germacrone-mediated podocyte protection in a mouse model of diabetic nephropathy in type I diabetes through triggering mitochondrial injury.
Wang Y; Feng F; He W; Sun L; He Q; Jin J
Bioengineered; 2022 Jan; 13(1):774-788. PubMed ID: 34847832
[TBL] [Abstract][Full Text] [Related]
51. Exploring the shared molecular mechanism of microvascular and macrovascular complications in diabetes: Seeking the hub of circulatory system injury.
Yuchen C; Hejia Z; Fanke M; Qixin D; Liyang C; Xi G; Yanxia C; Xiongyi Y; Zhuohang X; Guoguo Y; Min F
Front Endocrinol (Lausanne); 2023; 14():1032015. PubMed ID: 36755923
[TBL] [Abstract][Full Text] [Related]
52. The role of non-coding RNAs in diabetic nephropathy: potential applications as biomarkers for disease development and progression.
Alvarez ML; Distefano JK
Diabetes Res Clin Pract; 2013 Jan; 99(1):1-11. PubMed ID: 23102915
[TBL] [Abstract][Full Text] [Related]
53. Moringa oleifera Lam. seed extract protects kidney function in rats with diabetic nephropathy by increasing GSK-3β activity and activating the Nrf2/HO-1 pathway.
Wen Y; Liu Y; Huang Q; Liu R; Liu J; Zhang F; Liu S; Jiang Y
Phytomedicine; 2022 Jan; 95():153856. PubMed ID: 34856477
[TBL] [Abstract][Full Text] [Related]
54. Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy.
Shahni R; Gnudi L; King A; Jones P; Malik AN
Diabetologia; 2012 Mar; 55(3):825-34. PubMed ID: 22095236
[TBL] [Abstract][Full Text] [Related]
55. Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury.
Huang Y; Liu Y; Li L; Su B; Yang L; Fan W; Yin Q; Chen L; Cui T; Zhang J; Lu Y; Cheng J; Fu P; Liu F
BMC Nephrol; 2014 Sep; 15():142. PubMed ID: 25182190
[TBL] [Abstract][Full Text] [Related]
56. MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy.
Zhou H; Ni WJ; Meng XM; Tang LQ
Front Cell Dev Biol; 2020; 8():618536. PubMed ID: 33569382
[TBL] [Abstract][Full Text] [Related]
57. MicroRNAs and the glomerulus.
Kato M; Park JT; Natarajan R
Exp Cell Res; 2012 May; 318(9):993-1000. PubMed ID: 22421514
[TBL] [Abstract][Full Text] [Related]
58. MicroRNAs from urinary extracellular vesicles are non-invasive early biomarkers of diabetic nephropathy in type 2 diabetes patients with the 'Asian Indian phenotype'.
Prabu P; Rome S; Sathishkumar C; Gastebois C; Meugnier E; Mohan V; Balasubramanyam M
Diabetes Metab; 2019 Jun; 45(3):276-285. PubMed ID: 30165157
[TBL] [Abstract][Full Text] [Related]
59. Epigenetics in the pathogenesis of diabetic nephropathy.
Li X; Lu L; Hou W; Huang T; Chen X; Qi J; Zhao Y; Zhu M
Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(2):163-172. PubMed ID: 35130617
[TBL] [Abstract][Full Text] [Related]
60. Long non-coding RNA MEG3 promotes fibrosis and inflammatory response in diabetic nephropathy via miR-181a/Egr-1/TLR4 axis.
Zha F; Qu X; Tang B; Li J; Wang Y; Zheng P; Ji T; Zhu C; Bai S
Aging (Albany NY); 2019 Jun; 11(11):3716-3730. PubMed ID: 31195367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
